EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Review of Studies on HIV Pre-Exposure Prophylaxis in Community Pharmacies in States with Restrictive Pharmacist Prescription Authority in the United States

Hongmei Wang iD, Dominique Guinn iD, Xavier Roshitha Ramisetty, Thomas P Giordano iD, Ivy O Poon iD

Pharmacy · 24.09.2024 · 12 (5) · 144

DOI: 10.3390/pharmacy12050144 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacy, online erschienen am 24.09.2024. Verfasst von Hongmei Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIMHD NIH HHS, NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Community pharmacies have unparalleled potential to increase access to pre-exposure prophylaxis medications (PrEP) for HIV prevention; however, only 17 out of 50 states in the United States have statewide authority for pharmacists to provide PrEP at community pharmacies. Few studies have reported on how pharmacists overcome the legislative barrier and provide PrEP services in restrictive pharmacy prescription states. The objective of this article is to identify the existing primary literature describing pharmacist PrEP services in the community in states with restrictive prescription authority.

Methods

A systemic literature review was conducted to identify the primary literature that involved community pharmacy service and PrEP conducted in states that do not have expanded pharmacist prescriptive authority between 2000 to 2024.

Results

Ten publications were identified, describing nine studies, including four interview and survey studies, three intervention reports, and two ongoing clinical trials. None of these studies have a control group. Most pharmacists provide PrEP services in the community through a collaborative practice agreement with a primary care provider.

Conclusions

Future clinical studies with randomized controlled designs are required to test novel strategies in the education and implementation of pharmacy-led PrEP services in a community pharmacy setting to increase PrEP access.

Schlagwörter

Stichwörter der Autor:innen

HIVcommunity pharmacypharmacy servicepreexposure prophylaxis medications

Autor:innen und Institutionen

  • College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX 77004, USA.
  • Department of Pharmacy, Houston Methodist Hospital, Houston, TX 77030, USA.
  • Department of Health Kinesiology and Sports Studies, Texas Southern University, Houston, TX 77004, USA.
  • Section of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.

ORCID-Profile: Hongmei Wang, Dominique Guinn, Thomas P Giordano, Ivy O Poon

Förderung

  • NIAID NIH HHS
  • NIMHD NIH HHS
  • NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
  • National Institute on Minority Health and Health Disparities of the National Institutes of Health
  • Texas Developmental Center for AIDS Research

Zitieren

APA

Wang, H., Guinn, D., Ramisetty, X. R., Giordano, T. P., & Poon, I. O. (2024). A Review of Studies on HIV Pre-Exposure Prophylaxis in Community Pharmacies in States with Restrictive Pharmacist Prescription Authority in the United States. Pharmacy, 12(5), 144. https://doi.org/10.3390/pharmacy12050144

Vancouver

Wang H, Guinn D, Ramisetty XR, Giordano TP, Poon IO. A Review of Studies on HIV Pre-Exposure Prophylaxis in Community Pharmacies in States with Restrictive Pharmacist Prescription Authority in the United States. Pharmacy. 2024;12(5):144. doi:10.3390/pharmacy12050144

BibTeX
@article{Wang2024,
  author = {Wang, Hongmei and Guinn, Dominique and Ramisetty, Xavier Roshitha and Giordano, Thomas P and Poon, Ivy O},
  title = {A Review of Studies on HIV Pre-Exposure Prophylaxis in Community Pharmacies in States with Restrictive Pharmacist Prescription Authority in the United States},
  journal = {Pharmacy},
  year = {2024},
  volume = {12},
  number = {5},
  pages = {144},
  doi = {10.3390/pharmacy12050144}
}
Kostenlos starten →